Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Azarnoff

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Cancer Research|December 1, 1974
Effect of route of administration and effusions on methotrexate pharmacokineticsS H Wan, D H Huffman, D L Azarnoff, et al.
Arzneimittel-Forschung|January 1, 1976
Proceedings: Pharmacokinetics of drugs in patients with nephrotic syndromeD L Azarnoff, R Gugler, D W Shoeman, et al.
The American Journal of the Medical Sciences|May 1, 1979
A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patientsC A Dujovne, D L Azarnoff, P Pentikainen, et al.
The Journal of the Kansas Medical Society|March 1, 1972
Effective drug use. Drug utilization by the practicing physicianD L Azarnoff, J Doull, A Hurwitz, et al.
Clinical Pharmacology and Therapeutics|October 1, 1977
Glutethimide and 4-OH glutethimide: pharmacokinetics and effect on performance in manJ W Crow, P Lain, F Bochner, et al.
Journal of Chromatography|November 21, 1978
Quantitation of lidocaine and its deethylated metabolites in plasma and urine by gas chromatography-mass fragmentographyC E Hignite, C Tschanz, J Steiner, et al.
Clinical Pharmacology and Therapeutics|November 1, 1975
Panel 3: phase III investigationsD L Azarnoff, W B Abrams, J Cuttner, et al.
The Journal of Clinical Investigation|June 1, 1975
Pharmacokinetics of drugs in patients with the nephrotic syndromeR Gugler, D W Shoeman, D H Huffman, et al.
Cancer Research|February 1, 1974
Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine in humansS H Wan, D H Huffman, D L Azarnoff, et al.
The American Journal of the Medical Sciences|November 1, 1976
A two-year crossover therapeutic trial with halofenate and clofibrateC A Dujovne, D L Azarnoff, P Pentikainen, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Cancer Research|December 1, 1974
Effect of route of administration and effusions on methotrexate pharmacokineticsS H Wan, D H Huffman, D L Azarnoff, et al.
Arzneimittel-Forschung|January 1, 1976
Proceedings: Pharmacokinetics of drugs in patients with nephrotic syndromeD L Azarnoff, R Gugler, D W Shoeman, et al.
The American Journal of the Medical Sciences|May 1, 1979
A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patientsC A Dujovne, D L Azarnoff, P Pentikainen, et al.
The Journal of the Kansas Medical Society|March 1, 1972
Effective drug use. Drug utilization by the practicing physicianD L Azarnoff, J Doull, A Hurwitz, et al.
Clinical Pharmacology and Therapeutics|October 1, 1977
Glutethimide and 4-OH glutethimide: pharmacokinetics and effect on performance in manJ W Crow, P Lain, F Bochner, et al.
Journal of Chromatography|November 21, 1978
Quantitation of lidocaine and its deethylated metabolites in plasma and urine by gas chromatography-mass fragmentographyC E Hignite, C Tschanz, J Steiner, et al.
Clinical Pharmacology and Therapeutics|November 1, 1975
Panel 3: phase III investigationsD L Azarnoff, W B Abrams, J Cuttner, et al.
The Journal of Clinical Investigation|June 1, 1975
Pharmacokinetics of drugs in patients with the nephrotic syndromeR Gugler, D W Shoeman, D H Huffman, et al.
Cancer Research|February 1, 1974
Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine in humansS H Wan, D H Huffman, D L Azarnoff, et al.
The American Journal of the Medical Sciences|November 1, 1976
A two-year crossover therapeutic trial with halofenate and clofibrateC A Dujovne, D L Azarnoff, P Pentikainen, et al.
Pageof 12